YOLFTbeta
17

Bionet

1784 · TWO · Healthcare / Diagnostics & Research

47.40TWD+2.30 (+5.10%)

Price History

Full chart

Market Stats

Previous Close45.10
Open48.05
Day Range46.10 – 48.60
52-Week Range54.00 – 118.00
Volume114.19K
Market Cap3.14B
P/E (TTM)52.98
Forward P/E0.00
EPS1.14
Dividend Yield1.44%
Beta0.57
50-Day Avg60.07
200-Day Avg77.74

About

BIONET Corp. engages in cell therapy, regenerative medicine, medical big data, gene testing, and sales of biological and scientific information hardware and software business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells, as well as skin care products. It also provides storage and application of hematopoietic stem cells, analytical testing, clinical and preclinical research, commercialized cell-derived products, and Exosome, a cell-free therapy. The company was founded in 1989 and is based in Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Qing Yuan Kang
  • Employees0
  • HeadquartersXinhu 1st Road, Taipei, Taiwan, 114065, Taiwan
  • Websitehttps://www.bionetcorp.com

Leadership

  • Mr. Qing Yuan KangGeneral Manager
  • Peiyi LiuSenior Manager of Finance Department
  • Qianyu LiuAccounting Supervisor
  • Mei Hua LaiVice President of Administrative Office

Financials

Income Statement

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue697.40M770.61M775.56M806.58M921.42M980.38M1.13B1.22B1.24B
Growth (%)-+10.50%+0.64%+4.00%+14.24%+6.40%+14.99%+8.40%+1.19%
Cost of Revenue331.20M327.58M354.01M394.62M418.35M438.16M489.03M536.26M552.72M
Gross Profit366.20M443.03M421.55M411.96M503.07M542.22M638.28M685.77M683.87M
Gross Margin52.51%57.49%54.35%51.08%54.60%55.31%56.62%56.12%55.30%
Operating Expense369.05M408.88M412.71M404.39M461.17M468.17M529.18M622.77M695.98M
Operating Income-2.85M34.15M8.83M7.57M41.91M74.05M109.10M63.00M-12.11M
Operating Margin-0.41%4.43%1.14%0.94%4.55%7.55%9.68%5.16%-0.98%
EBITDA26.62M62.00M68.42M45.63M80.74M117.10M148.70M149.09M83.11M
EBITDA Margin3.82%8.05%8.82%5.66%8.76%11.94%13.19%12.20%6.72%
Net Income-6.27M24.23M6.80M12.74M26.62M37.97M78.40M83.70M51.43M
Net Income Margin-0.90%3.14%0.88%1.58%2.89%3.87%6.95%6.85%4.16%
R&D38.70M43.00M46.79M52.45M85.57M90.30M118.75M139.02M150.78M
R&D as % of Total Revenue5.55%5.58%6.03%6.50%9.29%9.21%10.53%11.38%12.19%
Interest Expense00609.00K329.00K389.00K458.00K410.00K1.28M1.50M
Interest Expense % of Total Revenue0.00%0.00%0.08%0.04%0.04%0.05%0.04%0.10%0.12%

Balance Sheet

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.82B1.78B1.76B1.73B1.78B1.84B2.35B3.16B3.08B
Total Liabilities453.33M443.09M453.87M445.44M468.19M513.97M626.47M760.40M822.58M
Total Equity1.12B1.10B1.07B1.08B1.10B1.08B1.19B1.33B1.27B
Cash122.41M96.05M78.94M128.36M121.80M161.61M238.49M242.79M256.05M
Total Debt---27.12M14.52M15.25M45.01M--
Net Debt----101.23M-107.28M-146.37M-193.48M--

Cash Flow

Currency: TWD2015-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--24.91M-12.97M2.67M73.66M13.88M94.65M153.09M176.49M148.04M
Investing Cash Flow-6.57M62.59M50.10M2.03M-4.59M----
Financing Cash Flow--7.18M-76.07M-69.66M-25.81M-15.60M-51.90M333.98M--
Capital Expenditure09.95M16.62M11.60M38.03M16.66M32.91M26.28M103.49M132.18M
Free Cash Flow--35.87M-29.80M-14.52M35.63M-2.79M61.74M126.81M73.00M15.86M
Dividends Paid-13.32M13.32M13.32M18.33M8.77M23.52M32.63M33.15M70.06M
FCF to OCF-144.01%229.68%-544.02%48.36%-20.08%65.23%82.83%41.36%10.71%
Dividend Paid to FCF--37.13%-44.70%-91.74%51.45%-314.64%38.09%25.73%45.41%441.87%

Earnings

Report DateJun 30, 2006Sep 30, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020May 13, 2021Aug 11, 2021Dec 1, 2021Mar 2, 2022Jun 1, 2022Aug 31, 2022Nov 30, 2022Mar 1, 2023May 31, 2023
EPS Estimate-------------------------------------------------------0.030.03-------
EPS Actual0.380.240.320.330.870.440.780.850.530.340.64-0.21-0.32-0.57-0.140.070.030.44-0.090.45-0.080.630.290.620.080.43-0.070.450.260.19-0.020.190.120.100.060.04-0.09-0.06-0.08-0.03-0.06-0.050.020.190.080.080.140.18-0.02-0.00-0.010.11-0.000.030.130.230.230.11-0.050.100.150.340.220.49
Surprise-------------------------------------------------------666.67%666.67%-------
Timing-------------------------------------------------------After-hoursAfter-hours-------

Key Statistics & Ratios

Market Cap3.14B
Enterprise Value1.93B
Trailing P/E52.98
Forward P/E0.00
Price / Sales2.42
Price / Book2.65
EPS1.14
Book Value24.63
Revenue (TTM)1.29B
Gross Profit (TTM)722.28M
EBITDA36.40M
Profit Margin4.42%
Operating Margin1.99%
Return on Equity0.38%
Return on Assets-0.32%
Shares Outstanding51.96M
Shares Float39.39M
Beta0.57
Dividend Yield1.44%
Dividend Rate0.88
Payout Ratio123.62%

Dividends

20251×
1.42Oct 3, 2025
20241×
0.71Sep 19, 2024
20231×
0.63Aug 31, 2023
20221×
0.44Sep 5, 2022
20211×
0.17Aug 2, 2021
20201×
0.11Jul 6, 2020
20191×
0.25Aug 28, 2019
20161×
0.37Jul 28, 2016
20151×
0.63Aug 27, 2015
20141×
0.92Sep 18, 2014
20131×
1.04Aug 14, 2013
20101×
1.66Sep 15, 2010
20091×
0.81Aug 25, 2009
20081×
1.22Aug 25, 2008

Stock Splits

  • Sep 19, 20241070.9238:1000
  • Sep 23, 20101020.89:1000
  • Aug 25, 2009103.151:100
  • Aug 25, 2008100.989:100